At the 42nd J.P. Morgan Healthcare Conference in San Francisco, NVIDIA CEO Jensen Huang highlighted the Innophore partnership as a key example of how generative AI is transforming drug discovery and protein engineering. The presentation showcased how Innophore’s Catalophore technology, combined with NVIDIA’s BioNeMo framework and GPU-accelerated computing, enables the rapid analysis of protein-ligand interactions at unprecedented scale. The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, attracting thousands of executives and investors worldwide.